Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARQL

ArQule (ARQL) Stock Price, News & Analysis

ArQule logo

About ArQule Stock (NASDAQ:ARQL)

Advanced Chart

Key Stats

Today's Range
$20.00
$20.00
50-Day Range
$20.00
$20.00
52-Week Range
$3.15
$20.45
Volume
N/A
Average Volume
5.27 million shs
Market Capitalization
$2.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ArQule and its competitors with MarketBeat's FREE daily newsletter.

ARQL Stock News Headlines

Netflix Inc DRC (NFLX34)
Merck Sharp & Dohme Corp.'s Net Worth
Elon Set to Shock the World on July 1st?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.
ASCO Live Blog: Saturday
Welcome to My Portfolio - Link your brokers or add lots
See More Headlines

ARQL Stock Analysis - Frequently Asked Questions

ArQule, Inc. (NASDAQ:ARQL) released its earnings results on Wednesday, October, 30th. The biotechnology company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.01. The biotechnology company had revenue of $0.21 million for the quarter, compared to the consensus estimate of $1.20 million. ArQule had a negative net margin of 805.61% and a negative trailing twelve-month return on equity of 33.10%.

Based on aggregate information from My MarketBeat watchlists, some other companies that ArQule investors own include Amarin (AMRN), Verastem (VSTM), Celldex Therapeutics (CLDX), Corbus Pharmaceuticals (CRBP), Advanced Micro Devices (AMD), Novavax (NVAX) and Axsome Therapeutics (AXSM).

Company Calendar

Last Earnings
10/30/2019
Today
8/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ARQL
CIK
1019695
Fax
N/A
Employees
36
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.48 million
Net Margins
-805.61%
Pretax Margin
N/A
Return on Equity
-33.10%
Return on Assets
-26.87%

Debt

Debt-to-Equity Ratio
0.08
Current Ratio
8.27
Quick Ratio
8.27

Sales & Book Value

Annual Sales
$25.76 million
Price / Sales
93.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.72 per share
Price / Book
27.78

Miscellaneous

Outstanding Shares
120,873,000
Free Float
N/A
Market Cap
$2.42 billion
Optionable
Optionable
Beta
2.49
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ARQL) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners